In the latest trading session, 0.75 million MAIA Biotechnology Inc (AMEX:MAIA) shares changed hands as the company’s beta touched 0.20. With the company’s most recent per share price at $2.38 changing hands around $0.26 or 12.26% at last look, the market valuation stands at $60.29M. MAIA’s current price is a discount, trading about -151.68% off its 52-week high of $5.99. The share price had its 52-week low at $0.99, which suggests the last value was 58.4% up since then. When we look at MAIA Biotechnology Inc’s average trading volume, we note the 10-day average is 0.4 million shares, with the 3-month average coming to 224.43K.
MAIA Biotechnology Inc (AMEX:MAIA) trade information
Instantly MAIA is in green as seen in intraday trades today. With action 6.73%, the performance over the past five days has been green. The company’s shares are showing year-to-date upside of 20.20%, with the 5-day performance at 6.73% in the green. However, in the 30-day time frame, MAIA Biotechnology Inc (AMEX:MAIA) is 10.19% up. Looking at the short shares, we see there were 0.66 million shares sold at short interest cover period of 10.99 days.
MAIA Biotechnology Inc (MAIA) estimates and forecasts
Data shows that the MAIA Biotechnology Inc share is performing relatively much not better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot -34.79% over the past 6 months, a 12.75% in annual growth rate that is considerably lower than the industry average of 16.40%.
According to analysts, the company will likely register a growth in its current quarter sales, forecast at 0.00%. The estimates for the next quarter sales put growth at 0.00%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -25.01%. The 2025 estimates are for MAIA Biotechnology Inc earnings to decrease by -7.69%.
MAIA Dividends
MAIA Biotechnology Inc is expected to release its next quarterly earnings report in February.
MAIA Biotechnology Inc (AMEX:MAIA)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 17.49% of MAIA Biotechnology Inc shares while 7.51% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 9.10%. There are 7.51% institutions holding the MAIA Biotechnology Inc stock share, with HALTER FERGUSON FINANCIAL INC. the top institutional holder. As of 2024-06-30, the company held 4.1% of the shares, roughly 0.72 million MAIA shares worth $2.47 million.
VANGUARD GROUP INC holds the second largest percentage of outstanding shares, with 3.051% or 0.54 million shares worth $1.84 million as of 2024-06-30.
Among Mutual Funds, the top two as of Sep 30, 2024 were Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund. With 401.59 shares estimated at $0.95 million under it, the former controlled 1.54% of total outstanding shares. On the other hand, Vanguard Extended Market Index Fund held about 0.59% of the shares, roughly 153.38 shares worth around $0.36 million.
